A growing number of investors and business tycoons are buying into the idea that medicines derived from psychedelic drugs might be the next big thing in Pharma.
Jumping on the bandwagon originally created by hippies – first critiqued and later accepted by philanthropists, activists, researchers and journalists. Big Pharma has realized the potential in psychotropic drugs and hoping to capitalize on the effects they have on the human mind.
Ancient Tribes used Psychedelics to “heal the mind” – but does that mean our minds are broken?
Psychedelics have long been used to “heal the mind” and “connect with a superior force that exists inside all of us” by ancient tribes all over the world. Mind-altering drugs have been used throughout human history without exception. Over the years, many self studies by scientists have shown conclusive results to spurt further studies by others and it is now at a turning point.
Pharmaceuticals are researching psychedelics. Maybe they see what our ancestors saw too. And they have a better explanation than “heal the mind”.
Modern pharma companies over the world are finally starting to realize the fact that our ancestors were actually on to something with psychedelics. Along with offering the user a chance to perceive reality in an altered state of consciousness, the effects of psychedelics are intriguing enough to attract the attention of researchers from all over.
Numerous startups all over the world are developing medicines from psilocybin, MDMA (ecstasy or molly), ibogaine and LSD – all of which are illegal in many countries all over the world. These companies have realized that while these drugs on their own, have specific effects, the right combination could be used to treat a slew of mental disorders that have silently ravaged human minds for centuries.
Research says that mental health conditions like anxiety and depression are what “we put ourselves in” and apparently, there is no external factor or medicine that can help us not be depressed or not be anxious simply by putting our mind off it – until now.
A bunch of research shows that there could be significant improvement in the mental health of a human that has experienced continued depreciation over the recent past. As more and more governmental regulations become lenient, more studies can be carried out to better understand the effects of these drugs that have dubbed “smart drugs” by a lot of users.
Research has conclusively linked the use of some psychedelics to the development of new neurons which means more connections in the brain – we all know what THAT means, right?
INCREASED BRAIN FUNCTIONS. This could mean a new dimension of growth in the human brain and new capabilities for these “neurologically evolved” humans.
Silicon Valley is growing shrooms…
Big tech and startups in the valley are teeming with professionals microdosing on psychedelics to increase performance. As there are more and more people accepting and using products like acid and papers and other forms of psychedelics like psilocybin mushrooms in daily life. There might be some conclusive evidence pointing towards better brain functions in the short term. It has also shown positive effects like boosted focus and “better mood” coming from an increased sense of awareness and connectivity.
But, all the great effects makes one weary of the side effects – what side effects could psychedelics have in the long term? What happens when you develop a tolerance towards increased quantities of psilocybin? If you stop taking the “medicine” will your brain shut down and make you a zombie?
Well, no one knows until studies have been completed.
Studies studies studies.
A growing number of studies show that the human population in general is interested in the intriguing effects of these drugs on the human mind. Could it be the key to our evolution?
One of the not so long ago psychedelic enthusiasts – Mr. Terence Mckenna, had reason to believe that psilocybin had something to do with the development of creativity in the humans that roamed the earth before civilization.
Why to believe in psychedelics?
Well, you could believe the words of a hippie or the words of countless psychiatrists that have published papers explaining their experience with these drugs and about treating patients with mental disorders – using these drugs in conjunction with psychiatric therapy.
Or, you could just understand that there is a growing trend with depression – the one mental disorder that psychedelics claim to be treating. Sales of anti-depressant drugs have crossed 1.3 Billion dollars in recent years and are expected to grow to 1.5 Billion in the coming year. This number is but a small example of the amount of success that some drugs can find only based on the fact that they “claim” to treat depression and anxiety.
With some studies of Psychedelics claiming the addition of new neurons thus sparking new developments in the brain… these “drugs” can be used in the battle against mental illnesses like Alzheimer’s disease, anxiety, indecision, etc. The pharma sector could find a lot of use for these compounds as the medicines currently in circulation do not prove to be as effective as “raw” forms of psychedelic medicines like psilocybin mushrooms.
Long Term Talk…
As more and more studies are carried out and published, people are starting to understand and accept the fact that these “drugs” that have been viewed in such a negative light by people all around the world just based on what the government propaganda has taught us. The truth about these substances might be far from what we have heard of them – yet. While high doses could be a problem and it is uncharted territory, microdosing has had some studies published and they are positive.
With little information on long term effects due to the infancy of the studies, more conclusive information can only be published in due time. Should the studies give favorable results and companies attain licenses from regulatory authorities, the industry emanating from psychedelic pharmaceuticals could stand to gain a substantial share of the anti-depressant market as we know it…